Specifically, m5C-mediated ALYREF recognizes RABL6 and TK1 mRNA m5C modification through its K171 domain, enhancing mRNA splicing and stability to increase bladder cancer malignancy (Wang et al., 2023b). The gene discussed is RABL6; the disease is urinary bladder carcinoma.